FDA Inspection 854874 — Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited — FEI 3008565058

The FDA completed an inspection of Glenmark Pharmaceuticals Limited on October 25, 2013 in Dhar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 25, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dhar (India)